Investors looking for a quick turnaround in the fortunes of Bayer are likely to be disappointed by chief executive Bill Anderson's assessment of the next couple of years as he delivers the group's ...

Global growth is expected to decline and downside risks to intensify as major policy shifts unfold After enduring a prolonged and unprecedented series of shocks, the global economy appeared to have ...